1. Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., et al. (2007). Cannabis in painful HIV-associated sensory neuropathy. Neurology, 68(7), 515–521. doi: 10.1212/01.wnl.0000253187.66183.9c
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th Ed.—Text Revision). Washington, DC: American Psychiatric Association.
3. Amico, K. R., Simoni, J. M., & Pantalone, D. W. (2012). Enhancing antiretroviral adherence: A 2012 update. In J. A. Trafton & W. Gordon (Eds.), Best practices in the behavioral management of chronic disease, Volume 2: Other medical disorders. Los Altos, Ca: Institute for Brain Potential.
4. Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., et al. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28(5), 445–449. doi: 10.1097/00126334-200112150-00006
5. Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G. (1992). AUDIT: The alcohol use disorders identification test (2nd ed.). Geneva, Switzerland: World Health Organization, Department of Mental Health and Substance Dependence.